Skip to main content

Kevin Campbell is interested in elucidating the molecular basis of muscular dystrophy, and in developing therapeutic strategies to treat it. Campbell and his team are currently focused on the enzymatic function of proteins that are required for the  post-translational modification of dystroglycan, a protein essential to maintaining skeletal muscle membrane integrity as well as the structure and function of the central nervous system. Their overall goals are to understand how dystroglycan functions, to identify and define the mechanisms that lead to muscular dystrophy, and to develop therapeutic strategies for these diseases.